Skip to content
Screener

Beta Bionics BBNX Other Income (Expense)

Other Income (Expense) at other companies

Insulet logo
InsuletPODD
-$1.1M-185%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$6.87M-16.1%
Medtronic logo
MedtronicMDT
$137M
Embecta Corp. logo
Embecta Corp.EMBC
$2.8M-41.7%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$2.84M-58.8%

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Reported directly by Beta Bionics in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income2,1773,0054,5535,441
Other expense(2)(2)(2)(2)
Change in fair value of warrant liabilities(12,450)
Total other income (expense), net2,1753,0034,551(7,011)
Net loss$(23,403)$(16,869)$(45,298)$(45,525)
Other comprehensive income (loss):
Unrealized gain (loss) on short-term and long-term investments(294)(91)(793)84
Comprehensive loss$(23,697)$(16,960)$(46,091)$(45,441)

Item 1. Financial Statements.

FAQ

What is Beta Bionics's other income (expense)?
Beta Bionics (BBNX) reported other income (expense) of $2.18M in Q2 2026.
How has Beta Bionics's other income (expense) changed year-over-year?
Beta Bionics's other income (expense) decreased by 27.6% year-over-year, from $3M to $2.18M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Beta Bionics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude